In the article “Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?”,1 which appeared in Volume 94, Issue 47 of Medicine, Dr. Fatih Saygili's name was omitted from the byline. The article has since been corrected online.
REFERENCE
- 1.Oztas E, Kuzu UB, Zengin NI, et al. Can serum ST2 levels be used as a marker of fibrosis in chronic hepatitis B infection? Medicine 2015. 94:e1889. [DOI] [PMC free article] [PubMed] [Google Scholar]